High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
- 15 February 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (4), 1015-1024
- https://doi.org/10.1158/1078-0432.ccr-07-1305
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant condition that predisposes to benign and malignant tumors. The lifetime risk of a malignant peripheral nerve sheath tumor (MPNST) in NF1 is approximately 10%. These tumors have a poor survival rate and their molecular basis remains unclear. We report the first comprehensive investigation of DNA copy number across multitude of genes in NF1 tumors using high-resolution array comparative genomic hybridization (CGH), with the aim to identify molecular signatures that delineate malignant from benign NF1 tumors. We constructed an exon-level resolution microarray encompassing 57 selected genes and profiled DNA from 35 MPNSTs, 16 plexiform, and 8 dermal neurofibromas. Bioinformatic analysis was done on array CGH data to identify concurrent aberrations in malignant tumors. The array CGH profiles of MPNSTs and neurofibromas were markedly different. A number of MPNST-specific alterations were identified, including amplifications of ITGB4, PDGFRA, MET, TP73, and HGF plus deletions in NF1, HMMR/RHAMM, MMP13, L1CAM2, p16INK4A/CDKN2A, and TP53. Copy number changes of HMMR/RHAMM, MMP13, p16INK4A/CDKN2A, and ITGB4 were observed in 46%, 43%, 39%, and 32%, respectively of the malignant tumors, implicating these genes in MPNST pathogenesis. Concomitant amplifications of HGF, MET, and PDGFRA genes were also revealed in MPNSTs, suggesting the putative role of p70S6K pathway in NF1 tumor progression. This study highlights the potential of array CGH in identifying novel diagnostic markers for MPNSTs.Keywords
Other Versions
This publication has 51 references indexed in Scilit:
- Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1Clinical Cancer Research, 2007
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Frequent amplifications and abundant expression ofTRIO,NKD2, andIRX2 in soft tissue sarcomasGenes, Chromosomes and Cancer, 2006
- A census of human cancer genesNature Reviews Cancer, 2004
- Malignant Peripheral Nerve Sheath TumorThe American Journal of Surgical Pathology, 2003
- Elevated Risk for MPNST in NF1 Microdeletion PatientsAmerican Journal of Human Genetics, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- NF1 Deletions in S-100 Protein-Positive and Negative Cells of Sporadic and Neurofibromatosis 1 (NF1)-Associated Plexiform Neurofibromas and Malignant Peripheral Nerve Sheath TumorsThe American Journal of Pathology, 2001
- Cytogenetic analysis of soft tissue sarcomas: Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST)Cancer Genetics and Cytogenetics, 1994